View More Recent Stories

Aug 1, 2019 07:00AM Blueprint Medicines Reports Second Quarter 2019 Financial Results
Jul 25, 2019 08:00AM Blueprint Medicines to Report Second Quarter 2019 Financial Results on Thursday, August 1, 2019
Jul 18, 2019 04:27PM Blueprint Medicines (BPMC) Announces EMA Validation of MAA for Avapritinib for the Treatment of PDGFRα D842V Mutant GIST and Fourth-Line GIST
Jul 18, 2019 04:01PM Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application for Avapritinib for the Treatment of PDGFRα D842V Mutant GIST and Fourth-Line GIST
Jun 17, 2019 06:13AM Blueprint Medicines (BPMC) Reports Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis
Jun 15, 2019 06:00AM Blueprint Medicines Presents Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis at 24th EHA Congress
Jun 14, 2019 08:51AM Blueprint Medicines (BPMC) Submits NDA to FDA for Avapritinib for Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
Jun 14, 2019 08:45AM Blueprint Medicines Submits New Drug Application to U.S. Food and Drug Administration for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
Jun 3, 2019 09:04AM Blueprint Medicines (BPMC) Reports Updated Data from Ongoing ARROW Trial of BLU-667 at ASCO 2019 Meeting
Jun 3, 2019 09:00AM Blueprint Medicines' Highly Selective RET Inhibitor BLU-667 Shows Durable Anti-Tumor Activity in Patients with RET-Altered Cancers in Updated ARROW Trial Data Presented at ASCO 2019
Jun 1, 2019 09:00AM Blueprint Medicines Presents NAVIGATOR Trial Data in PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST at ASCO 2019 Supporting Planned Marketing Applications for Avapritinib
May 29, 2019 04:00PM Blueprint Medicines to Present at Upcoming Investor Conferences in June
May 16, 2019 09:00AM Blueprint Medicines Announces Data Presentations at ASCO and EHA Meetings from Registration-Enabling Clinical Trials of Avapritinib and BLU-667 Across Multiple Patient Populations
May 9, 2019 07:00AM Blueprint Medicines Reports First Quarter 2019 Financial Results
May 8, 2019 08:00AM Blueprint Medicines to Present at Bank of America Merrill Lynch 2019 Health Care Conference
May 2, 2019 08:00AM Blueprint Medicines to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019
Mar 5, 2019 08:01AM Blueprint Medicines to Present at 39th Annual Cowen & Co. Health Care Conference
Feb 26, 2019 07:00AM Blueprint Medicines Reports Fourth Quarter and Full Year 2018 Financial Results
Feb 19, 2019 08:00AM Blueprint Medicines to Report Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019
Feb 7, 2019 04:01PM Blueprint Medicines to Present at Upcoming Investor Conferences in February
Jan 4, 2019 08:09AM Blueprint Medicines (BPMC) Provides '2020 Blueprint' Global Business Strategy & Outlines Key Corporate Goals
Jan 4, 2019 08:00AM Blueprint Medicines Announces "2020 Blueprint" Global Business Strategy and Outlines Key Corporate Goals
Feb 21, 2018 07:01AM Blueprint Medicines Reports Fourth Quarter and Full Year 2017 Financial Results
Oct 31, 2017 07:00AM Blueprint Medicines Reports Third Quarter 2017 Financial Results
Aug 2, 2017 07:00AM Blueprint Medicines Reports Second Quarter 2017 Financial Results
View More Recent Stories